QUO VADIS

​A prospective observational study to evaluate the relationship between disease state and change in quality of life in Ankylosing Spondylitis patients treated with Remicade (infliximab) or Simponi (golimumab)​

Sponsor: Merck Sharp & Dohm Corp​